About Us

Mr. Bai is a technology investor at T. Rowe Price, where he focuses on long-term investment opportunities across the global TMT sector in both public and private markets.

Prior to joining T. Rowe Price, he served as an Executive Director at Destination Partners Asset Management, where he focused on private equity–style fundamental investing. He also worked at Balyasny Asset Management, focusing on long/short investments in Asia TMT sectors.

He began his career at Morgan Stanley in Hong Kong, working in both the Investment Banking Division and Morgan Stanley Private Equity (MSPE).

Mr. Bai received his Bachelor's degree with honors in Microelectronics and Business Administration from Shanghai Jiao Tong University.

Dr. Christo is Chief and Associate Professor of the Division of Pain Medicine at the Johns Hopkins University School of Medicine. He previously served as Director of both the Multidisciplinary Pain Fellowship Program and the Blaustein Pain Treatment Center at Johns Hopkins Hospital.

Dr. Christo is a nationally recognized pain specialist whose work spans clinical care, research, medical education, and patient advocacy. He has published more than 100 articles and book chapters, co-edited five textbooks on pain medicine, and serves on multiple journal editorial boards and advisory committees.

His honors include the John and Emma Bonica Public Service Award from the American Pain Society, the Patient Advocacy Award from the American Academy of Pain Medicine, and Pain Educator of the Year from the American Society of Pain Educators. He has also been inducted into the Miller Coulson Academy of Clinical Excellence.

Dr. Christo received his bachelor's degree from the University of Notre Dame, his medical degree from the University of Louisville School of Medicine, and his MBA from the Johns Hopkins Carey Business School.

Dr. Geng is a member of O'Melveny & Myers' Policy Committee and managing partner of the Beijing office.

Dr. Geng is recognized for his exceptional skills and his outstanding record of successfully handling high-profile cross-border matters. Recent accolades include being named a "Dealmakers of Asia" by Asian Legal Business (2024-2025); one of the top lawyers in China as recognized by China Business Law Journal in its "A-list: the Visionaries" (2020-2026); and "Leading Lawyer" by The Legal 500 Asia Pacific (2026).

Dr. Geng led the O'Melveny team for RemeGen's Hong Kong IPO, which was recognized as "Deal of the Year" by China Business Law Journal and "Megatrend Deal of the Year – Healthcare" by FinanceAsia. Dr. Geng is highly rated for China capital markets by Chambers Asia Pacific, Chambers Greater China Region and Chambers Global.

Dr. Geng received his Bachelor's degree in Biology from Peking University and a Ph.D. in Biochemistry from New York University.

Ms. Li is Head of Partnerships at Chargeblast, where she leads global partnerships and go-to-market strategy for a chargeback mitigation platform serving thousands of merchants and billions in transaction volume, with integrations across major processors including Stripe, Adyen, Checkout.com, and Airwallex.

Prior to Chargeblast, she worked in venture capital and institutional engagement at Palm Drive Capital and the Robert F. Kennedy Human Rights Center, and earlier in sales and trading roles across global investment banks.

She is also the Founder & CEO of Lumina, a venture studio and talent platform focused on creator–brand partnerships.

Ms. Li received her Bachelor's degree in Computer Science and Media, Culture & Communication, and a Master of Public Administration from New York University.

Mr. Ponzo is a Member of the Technical Staff at Adapter, where he builds agentic backend systems for large-scale data ingestion, understanding, and real-time orchestration.

Prior to Adapter, he was a Software Development Engineer at Amazon Web Services (AWS), working across AI/ML and AWS Service Catalog.

He previously worked as a researcher at the Johns Hopkins University Applied Physics Laboratory, focusing on multi-scale geotemporal modeling.

Mr. Ponzo received his Master of Science in Engineering in Computer Science and his Bachelor's degree in Environmental Engineering from Johns Hopkins University.

Mr. Wang joined Cedarlake Capital in 2015 and currently serves as a Partner.

Prior to Cedarlake Capital, he held senior positions at Fosun Group and Istithmar World, a member of Dubai World.

He brings nearly 20 years of professional experience in private equity and venture capital investments.

Mr. Wang also serves as a director of Iluvatar CoreX (9903.HK) and Axera Semiconductor (0600.HK), both listed on the Hong Kong Stock Exchange.

Mr. Wang received his MBA from the Carey Business School at Johns Hopkins University, and his Bachelor of Economics from Shanghai University of Finance and Economics.